LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 7838 | 10512 | 0.7457 | 0.8368 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 4226 | 10512 | 0.4026 | 0.5352 |
MCF 10A | Fedratinib | 10 | uM | LJP5 | 72 | hr | 962 | 1123 | 10512 | 0.1069 | 0.0459 |
MCF 10A | Trametinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 1790 | 10512 | 0.1702 | 0.1960 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 1803 | 10512 | 0.1716 | 0.1996 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 1899 | 10512 | 0.1809 | 0.2179 |
MCF 10A | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 1832 | 10512 | 0.1746 | 0.2051 |
MCF 10A | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1925 | 10512 | 0.1834 | 0.2221 |
MCF 10A | Trametinib | 10 | uM | LJP5 | 72 | hr | 962 | 1979 | 10512 | 0.1884 | 0.2326 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 962 | 1009 | 10692 | 0.0944 | 0.0134 |
MCF 10A | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 962 | 853 | 10692 | 0.0798 | -0.0343 |
MCF 10A | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 962 | 899 | 10692 | 0.0841 | -0.0201 |
MCF 10A | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 962 | 872 | 10692 | 0.0816 | -0.0278 |
MCF 10A | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 962 | 752 | 10692 | 0.0703 | -0.0687 |
MCF 10A | Omipalisib | 10 | uM | LJP6 | 72 | hr | 962 | 720 | 10692 | 0.0674 | -0.0800 |
MCF 10A | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10708 | 10512 | 1.0185 | 1.0105 |
MCF 10A | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10235 | 10512 | 0.9736 | 0.9845 |
MCF 10A | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9430 | 10512 | 0.8972 | 0.9381 |
MCF 10A | Buparlisib | 1.11 | uM | LJP5 | 72 | hr | 962 | 6073 | 10512 | 0.5777 | 0.7058 |
MCF 10A | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1383 | 10512 | 0.1316 | 0.1109 |
MCF 10A | Buparlisib | 10 | uM | LJP5 | 72 | hr | 962 | 586 | 10512 | 0.0558 | -0.1348 |
MCF 10A | XL147 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10737 | 10512 | 1.0214 | 1.0123 |
MCF 10A | XL147 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10032 | 10512 | 0.9544 | 0.9731 |
MCF 10A | XL147 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9449 | 10512 | 0.8988 | 0.9390 |
MCF 10A | XL147 | 1.11 | uM | LJP5 | 72 | hr | 962 | 8797 | 10512 | 0.8369 | 0.8994 |